Prognostic value of <it>KRAS </it>genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to ext... by Bruera Gemma, Cannita Katia, Di Giacomo Daniela, Lamy Aude, Troncone Giancarlo, Dal Mas Antonella, Coletti Gino, Frébourg Thierry, Sabourin Jean, Tosi Mario, Ficorella Corrado, Ricevuto Enrico

Get full text